The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Microarray Patch Transdermal Drug Delivery Systems Market Research Report 2025
Synopsis
Microarray patch transdermal drug delivery systems consist of tiny protrusions that stick to the body like small bandages that painlessly penetrate the outermost layer of the skin to deliver the drug or vaccine to the top layer of the skin. This drug delivery system is simpler than traditional drug delivery methods and can also reduce a certain risk of infection, ensuring the safety of patients.
Global Microarray Patch Transdermal Drug Delivery Systems market is projected to reach US$ 8345 million in 2029, increasing from US$ 5615 million in 2022, with the CAGR of 6.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Microarray Patch Transdermal Drug Delivery Systems market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Microarray Patch Transdermal Drug Delivery Systems market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
3M
Becton
Endoderma
BD
Raphas
Nanopass Tech
Corium International
Nitto Denko
Microdermics
TheraJect
Vaxxas
KINDEVA
QuadMedicine
Lohmann Therapie-Systeme
AdminMed Nano BioSciences
Segment by Type
Solid Microneedles
Hollow Microneedles
Dissolving Microneedles
Segment by Application
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Microarray Patch Transdermal Drug Delivery Systems report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Microarray patch transdermal drug delivery systems consist of tiny protrusions that stick to the body like small bandages that painlessly penetrate the outermost layer of the skin to deliver the drug or vaccine to the top layer of the skin. This drug delivery system is simpler than traditional drug delivery methods and can also reduce a certain risk of infection, ensuring the safety of patients.
Global Microarray Patch Transdermal Drug Delivery Systems market is projected to reach US$ 8345 million in 2029, increasing from US$ 5615 million in 2022, with the CAGR of 6.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Microarray Patch Transdermal Drug Delivery Systems market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Microarray Patch Transdermal Drug Delivery Systems market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
3M
Becton
Endoderma
BD
Raphas
Nanopass Tech
Corium International
Nitto Denko
Microdermics
TheraJect
Vaxxas
KINDEVA
QuadMedicine
Lohmann Therapie-Systeme
AdminMed Nano BioSciences
Segment by Type
Solid Microneedles
Hollow Microneedles
Dissolving Microneedles
Segment by Application
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Microarray Patch Transdermal Drug Delivery Systems report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Microarray Patch Transdermal Drug Delivery Systems Market Overview
1.1 Product Overview and Scope of Microarray Patch Transdermal Drug Delivery Systems
1.2 Microarray Patch Transdermal Drug Delivery Systems Segment by Type
1.2.1 Global Microarray Patch Transdermal Drug Delivery Systems Market Value Comparison by Type (2023-2029)
1.2.2 Solid Microneedles
1.2.3 Hollow Microneedles
1.2.4 Dissolving Microneedles
1.3 Microarray Patch Transdermal Drug Delivery Systems Segment by Application
1.3.1 Global Microarray Patch Transdermal Drug Delivery Systems Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Specialty Clinics
1.3.5 Others
1.4 Global Microarray Patch Transdermal Drug Delivery Systems Market Size Estimates and Forecasts
1.4.1 Global Microarray Patch Transdermal Drug Delivery Systems Revenue 2018-2029
1.4.2 Global Microarray Patch Transdermal Drug Delivery Systems Sales 2018-2029
1.4.3 Global Microarray Patch Transdermal Drug Delivery Systems Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Microarray Patch Transdermal Drug Delivery Systems Market Competition by Manufacturers
2.1 Global Microarray Patch Transdermal Drug Delivery Systems Sales Market Share by Manufacturers (2018-2023)
2.2 Global Microarray Patch Transdermal Drug Delivery Systems Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Microarray Patch Transdermal Drug Delivery Systems Average Price by Manufacturers (2018-2023)
2.4 Global Microarray Patch Transdermal Drug Delivery Systems Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Microarray Patch Transdermal Drug Delivery Systems, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Microarray Patch Transdermal Drug Delivery Systems, Product Type & Application
2.7 Microarray Patch Transdermal Drug Delivery Systems Market Competitive Situation and Trends
2.7.1 Microarray Patch Transdermal Drug Delivery Systems Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Microarray Patch Transdermal Drug Delivery Systems Players Market Share by Revenue
2.7.3 Global Microarray Patch Transdermal Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Microarray Patch Transdermal Drug Delivery Systems Retrospective Market Scenario by Region
3.1 Global Microarray Patch Transdermal Drug Delivery Systems Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Microarray Patch Transdermal Drug Delivery Systems Global Microarray Patch Transdermal Drug Delivery Systems Sales by Region: 2018-2029
3.2.1 Global Microarray Patch Transdermal Drug Delivery Systems Sales by Region: 2018-2023
3.2.2 Global Microarray Patch Transdermal Drug Delivery Systems Sales by Region: 2024-2029
3.3 Global Microarray Patch Transdermal Drug Delivery Systems Global Microarray Patch Transdermal Drug Delivery Systems Revenue by Region: 2018-2029
3.3.1 Global Microarray Patch Transdermal Drug Delivery Systems Revenue by Region: 2018-2023
3.3.2 Global Microarray Patch Transdermal Drug Delivery Systems Revenue by Region: 2024-2029
3.4 North America Microarray Patch Transdermal Drug Delivery Systems Market Facts & Figures by Country
3.4.1 North America Microarray Patch Transdermal Drug Delivery Systems Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Microarray Patch Transdermal Drug Delivery Systems Sales by Country (2018-2029)
3.4.3 North America Microarray Patch Transdermal Drug Delivery Systems Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Microarray Patch Transdermal Drug Delivery Systems Market Facts & Figures by Country
3.5.1 Europe Microarray Patch Transdermal Drug Delivery Systems Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Microarray Patch Transdermal Drug Delivery Systems Sales by Country (2018-2029)
3.5.3 Europe Microarray Patch Transdermal Drug Delivery Systems Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Microarray Patch Transdermal Drug Delivery Systems Market Facts & Figures by Country
3.6.1 Asia Pacific Microarray Patch Transdermal Drug Delivery Systems Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Microarray Patch Transdermal Drug Delivery Systems Sales by Country (2018-2029)
3.6.3 Asia Pacific Microarray Patch Transdermal Drug Delivery Systems Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Microarray Patch Transdermal Drug Delivery Systems Market Facts & Figures by Country
3.7.1 Latin America Microarray Patch Transdermal Drug Delivery Systems Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Microarray Patch Transdermal Drug Delivery Systems Sales by Country (2018-2029)
3.7.3 Latin America Microarray Patch Transdermal Drug Delivery Systems Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Microarray Patch Transdermal Drug Delivery Systems Market Facts & Figures by Country
3.8.1 Middle East and Africa Microarray Patch Transdermal Drug Delivery Systems Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Microarray Patch Transdermal Drug Delivery Systems Sales by Country (2018-2029)
3.8.3 Middle East and Africa Microarray Patch Transdermal Drug Delivery Systems Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Microarray Patch Transdermal Drug Delivery Systems Sales by Type (2018-2029)
4.1.1 Global Microarray Patch Transdermal Drug Delivery Systems Sales by Type (2018-2023)
4.1.2 Global Microarray Patch Transdermal Drug Delivery Systems Sales by Type (2024-2029)
4.1.3 Global Microarray Patch Transdermal Drug Delivery Systems Sales Market Share by Type (2018-2029)
4.2 Global Microarray Patch Transdermal Drug Delivery Systems Revenue by Type (2018-2029)
4.2.1 Global Microarray Patch Transdermal Drug Delivery Systems Revenue by Type (2018-2023)
4.2.2 Global Microarray Patch Transdermal Drug Delivery Systems Revenue by Type (2024-2029)
4.2.3 Global Microarray Patch Transdermal Drug Delivery Systems Revenue Market Share by Type (2018-2029)
4.3 Global Microarray Patch Transdermal Drug Delivery Systems Price by Type (2018-2029)
5 Segment by Application
5.1 Global Microarray Patch Transdermal Drug Delivery Systems Sales by Application (2018-2029)
5.1.1 Global Microarray Patch Transdermal Drug Delivery Systems Sales by Application (2018-2023)
5.1.2 Global Microarray Patch Transdermal Drug Delivery Systems Sales by Application (2024-2029)
5.1.3 Global Microarray Patch Transdermal Drug Delivery Systems Sales Market Share by Application (2018-2029)
5.2 Global Microarray Patch Transdermal Drug Delivery Systems Revenue by Application (2018-2029)
5.2.1 Global Microarray Patch Transdermal Drug Delivery Systems Revenue by Application (2018-2023)
5.2.2 Global Microarray Patch Transdermal Drug Delivery Systems Revenue by Application (2024-2029)
5.2.3 Global Microarray Patch Transdermal Drug Delivery Systems Revenue Market Share by Application (2018-2029)
5.3 Global Microarray Patch Transdermal Drug Delivery Systems Price by Application (2018-2029)
6 Key Companies Profiled
6.1 3M
6.1.1 3M Corporation Information
6.1.2 3M Description and Business Overview
6.1.3 3M Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.1.4 3M Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
6.1.5 3M Recent Developments/Updates
6.2 Becton
6.2.1 Becton Corporation Information
6.2.2 Becton Description and Business Overview
6.2.3 Becton Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Becton Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
6.2.5 Becton Recent Developments/Updates
6.3 Endoderma
6.3.1 Endoderma Corporation Information
6.3.2 Endoderma Description and Business Overview
6.3.3 Endoderma Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Endoderma Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
6.3.5 Endoderma Recent Developments/Updates
6.4 BD
6.4.1 BD Corporation Information
6.4.2 BD Description and Business Overview
6.4.3 BD Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.4.4 BD Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
6.4.5 BD Recent Developments/Updates
6.5 Raphas
6.5.1 Raphas Corporation Information
6.5.2 Raphas Description and Business Overview
6.5.3 Raphas Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Raphas Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
6.5.5 Raphas Recent Developments/Updates
6.6 Nanopass Tech
6.6.1 Nanopass Tech Corporation Information
6.6.2 Nanopass Tech Description and Business Overview
6.6.3 Nanopass Tech Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Nanopass Tech Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
6.6.5 Nanopass Tech Recent Developments/Updates
6.7 Corium International
6.6.1 Corium International Corporation Information
6.6.2 Corium International Description and Business Overview
6.6.3 Corium International Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Corium International Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
6.7.5 Corium International Recent Developments/Updates
6.8 Nitto Denko
6.8.1 Nitto Denko Corporation Information
6.8.2 Nitto Denko Description and Business Overview
6.8.3 Nitto Denko Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Nitto Denko Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
6.8.5 Nitto Denko Recent Developments/Updates
6.9 Microdermics
6.9.1 Microdermics Corporation Information
6.9.2 Microdermics Description and Business Overview
6.9.3 Microdermics Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Microdermics Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
6.9.5 Microdermics Recent Developments/Updates
6.10 TheraJect
6.10.1 TheraJect Corporation Information
6.10.2 TheraJect Description and Business Overview
6.10.3 TheraJect Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.10.4 TheraJect Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
6.10.5 TheraJect Recent Developments/Updates
6.11 Vaxxas
6.11.1 Vaxxas Corporation Information
6.11.2 Vaxxas Microarray Patch Transdermal Drug Delivery Systems Description and Business Overview
6.11.3 Vaxxas Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Vaxxas Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
6.11.5 Vaxxas Recent Developments/Updates
6.12 KINDEVA
6.12.1 KINDEVA Corporation Information
6.12.2 KINDEVA Microarray Patch Transdermal Drug Delivery Systems Description and Business Overview
6.12.3 KINDEVA Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.12.4 KINDEVA Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
6.12.5 KINDEVA Recent Developments/Updates
6.13 QuadMedicine
6.13.1 QuadMedicine Corporation Information
6.13.2 QuadMedicine Microarray Patch Transdermal Drug Delivery Systems Description and Business Overview
6.13.3 QuadMedicine Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.13.4 QuadMedicine Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
6.13.5 QuadMedicine Recent Developments/Updates
6.14 Lohmann Therapie-Systeme
6.14.1 Lohmann Therapie-Systeme Corporation Information
6.14.2 Lohmann Therapie-Systeme Microarray Patch Transdermal Drug Delivery Systems Description and Business Overview
6.14.3 Lohmann Therapie-Systeme Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Lohmann Therapie-Systeme Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
6.14.5 Lohmann Therapie-Systeme Recent Developments/Updates
6.15 AdminMed Nano BioSciences
6.15.1 AdminMed Nano BioSciences Corporation Information
6.15.2 AdminMed Nano BioSciences Microarray Patch Transdermal Drug Delivery Systems Description and Business Overview
6.15.3 AdminMed Nano BioSciences Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.15.4 AdminMed Nano BioSciences Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
6.15.5 AdminMed Nano BioSciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Microarray Patch Transdermal Drug Delivery Systems Industry Chain Analysis
7.2 Microarray Patch Transdermal Drug Delivery Systems Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Microarray Patch Transdermal Drug Delivery Systems Production Mode & Process
7.4 Microarray Patch Transdermal Drug Delivery Systems Sales and Marketing
7.4.1 Microarray Patch Transdermal Drug Delivery Systems Sales Channels
7.4.2 Microarray Patch Transdermal Drug Delivery Systems Distributors
7.5 Microarray Patch Transdermal Drug Delivery Systems Customers
8 Microarray Patch Transdermal Drug Delivery Systems Market Dynamics
8.1 Microarray Patch Transdermal Drug Delivery Systems Industry Trends
8.2 Microarray Patch Transdermal Drug Delivery Systems Market Drivers
8.3 Microarray Patch Transdermal Drug Delivery Systems Market Challenges
8.4 Microarray Patch Transdermal Drug Delivery Systems Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
